JP2005538109A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005538109A5 JP2005538109A5 JP2004524924A JP2004524924A JP2005538109A5 JP 2005538109 A5 JP2005538109 A5 JP 2005538109A5 JP 2004524924 A JP2004524924 A JP 2004524924A JP 2004524924 A JP2004524924 A JP 2004524924A JP 2005538109 A5 JP2005538109 A5 JP 2005538109A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibitor
- compound
- pharmaceutical composition
- compound according
- agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*c(c(IC)c1)cc2c1OC(*)(*)[C@](C)C(*)C2*(C)C Chemical compound C*c(c(IC)c1)cc2c1OC(*)(*)[C@](C)C(*)C2*(C)C 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N c1ccccc1 Chemical compound c1ccccc1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39951802P | 2002-07-30 | 2002-07-30 | |
| PCT/US2003/023499 WO2004010992A1 (en) | 2002-07-30 | 2003-07-25 | Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005538109A JP2005538109A (ja) | 2005-12-15 |
| JP2005538109A5 true JP2005538109A5 (cg-RX-API-DMAC7.html) | 2006-09-07 |
| JP4505327B2 JP4505327B2 (ja) | 2010-07-21 |
Family
ID=31188591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004524924A Expired - Fee Related JP4505327B2 (ja) | 2002-07-30 | 2003-07-25 | 異常脂血症および他の脂質障害の治療用のPPARα選択的化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7297715B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1539137B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4505327B2 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE468851T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003256911B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2493913A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60332738D1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004010992A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS20050532A (sr) | 2003-01-14 | 2007-12-31 | Arena Pharmaceuticals Inc., | Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija |
| AU2004231106A1 (en) * | 2003-04-14 | 2004-10-28 | The Institutes For Pharmaceutical Discovery, Llc | N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| EA200501710A1 (ru) | 2003-04-30 | 2006-06-30 | ДЗЕ ИНСТИТЬЮТС ФОР ФАРМАСЬЮТИКАЛ ДИСКАВЕРИ, ЭлЭлСи | Замещённые карбоновые кислоты |
| KR20060056944A (ko) | 2003-07-14 | 2006-05-25 | 아레나 파마슈티칼스, 인크. | 대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료 |
| WO2005024057A1 (en) * | 2003-09-10 | 2005-03-17 | Galapagos Genomics N.V. | Method of identifying a compound that changes the amyloid-beta precursor protein processing in a cell |
| EP1566202A1 (en) * | 2004-02-23 | 2005-08-24 | Sahltech I Göteborg AB | Use of resistin antagonists in the treatment of rheumatoid arthritis |
| MX2007001634A (es) | 2004-08-11 | 2007-04-23 | Kyorin Seiyaku Kk | Nuevo derivado de acido amino benzoico ciclico. |
| MY148521A (en) | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| US20090036489A1 (en) * | 2005-03-22 | 2009-02-05 | Masahiro Nomura | Novel Cyclic Aminophenylalkanoic Acid Derivative |
| WO2008091338A1 (en) * | 2007-01-23 | 2008-07-31 | Reddy Us Therapeutics, Inc. | Methods and compositions for the treatment of insulin resistance, diabetes, and diabetes-associated dyslipidemia |
| US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| WO2008128126A1 (en) | 2007-04-11 | 2008-10-23 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US8142826B2 (en) * | 2007-11-05 | 2012-03-27 | Naturex, Inc. | Extract of Fraxinus excelsior seeds and therapeutic applications therefor |
| US8883721B2 (en) * | 2009-05-12 | 2014-11-11 | Mcgill University | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| US9724381B2 (en) | 2009-05-12 | 2017-08-08 | The Administrators Of The Tulane Educational Fund | Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof |
| WO2011159917A2 (en) | 2010-06-16 | 2011-12-22 | The Administrators Of The Tulane Educational Fund | Growth hormone secretatogue receptor antagonists and uses thereof |
| CN103221410B (zh) | 2010-09-22 | 2017-09-15 | 艾尼纳制药公司 | Gpr119受体调节剂和对与其相关的障碍的治疗 |
| CA3002540C (en) | 2015-01-06 | 2023-11-07 | Arena Pharmaceuticals, Inc. | Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor |
| JP6838744B2 (ja) | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ, インコーポレイテッド | S1P1レセプター関連障害における使用のための(R)−2−(7−(4−シクロペンチル−3−(トリフルオロメチル)ベンジルオキシ)−1,2,3,4−テトラヒドロシクロペンタ[b]インドール−3−イル)酢酸(化合物1)の結晶性L−アルギニン塩 |
| CN110520124A (zh) | 2017-02-16 | 2019-11-29 | 艾尼纳制药公司 | 用于治疗原发性胆汁性胆管炎的化合物和方法 |
| KR101934197B1 (ko) * | 2017-06-12 | 2018-12-31 | 아주대학교산학협력단 | PPARα/γ 이중 작용 활성을 갖는 신규 화합물 및 이를 유효성분으로 함유하는 대사질환 예방 또는 치료용 조성물 |
| JP7397011B2 (ja) | 2018-06-06 | 2023-12-12 | アリーナ ファーマシューティカルズ, インコーポレイテッド | S1p1受容体に関連する状態を治療する方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4565882A (en) * | 1984-01-06 | 1986-01-21 | G. D. Searle & Co. | Substituted dihydrobenzopyran-2-carboxylates |
| US5273999A (en) * | 1991-09-10 | 1993-12-28 | Hoffmann-La Roche Inc. | Carboxylic acid leukotriene B4 antagonists |
| NZ515087A (en) * | 1999-04-28 | 2003-11-28 | Aventis Pharma Gmbh | Tri-aryl acid derivatives as PPAR receptor ligands |
| FR2802808B1 (fr) * | 1999-12-22 | 2002-08-09 | Oreal | Utilisation de composes polycycliques aromatiques en tant qu'activateurs des recepteurs de type ppars dans une composition cosmetique ou pharmaceutique |
| JP2004513090A (ja) * | 2000-09-27 | 2004-04-30 | メルク エンド カムパニー インコーポレーテッド | 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体 |
| JP2002114781A (ja) * | 2000-10-06 | 2002-04-16 | Sankyo Co Ltd | 置換縮合イミダゾール誘導体を含有する糖尿病の予防剤、治療剤 |
-
2003
- 2003-07-25 JP JP2004524924A patent/JP4505327B2/ja not_active Expired - Fee Related
- 2003-07-25 CA CA002493913A patent/CA2493913A1/en not_active Abandoned
- 2003-07-25 US US10/522,646 patent/US7297715B2/en not_active Expired - Fee Related
- 2003-07-25 EP EP03771947A patent/EP1539137B1/en not_active Expired - Lifetime
- 2003-07-25 DE DE60332738T patent/DE60332738D1/de not_active Expired - Lifetime
- 2003-07-25 AU AU2003256911A patent/AU2003256911B2/en not_active Ceased
- 2003-07-25 WO PCT/US2003/023499 patent/WO2004010992A1/en not_active Ceased
- 2003-07-25 AT AT03771947T patent/ATE468851T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2510540A1 (en) | Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 | |
| CA2488592A1 (en) | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia | |
| US7041837B2 (en) | Heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
| JP2006500384A5 (cg-RX-API-DMAC7.html) | ||
| JP5786034B2 (ja) | 脂質異常症の治療に適したヘテロ環式化合物 | |
| CA2525764A1 (en) | N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors | |
| JP2005511634A5 (cg-RX-API-DMAC7.html) | ||
| HRP20241674T1 (hr) | 6'-[[(1s,3s)-3-[[5-(difluormetoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i postupci njegove upotrebe | |
| CA2463154A1 (en) | Heterocyclic compounds and methods of use | |
| JP2022116083A5 (cg-RX-API-DMAC7.html) | ||
| JP2004513076A5 (cg-RX-API-DMAC7.html) | ||
| US9572798B2 (en) | Therapeutic agent for dyslipidemia | |
| JP2016500063A5 (cg-RX-API-DMAC7.html) | ||
| JP2011528362A5 (cg-RX-API-DMAC7.html) | ||
| HRP20120476T1 (hr) | Derivati 4-benzilamino-1-karboksiacil-piperidina kao cetp inhibitori korisni za liječenje bolesti kao što su hiperlipidemija ili arterioskleroza | |
| JP2008513516A5 (cg-RX-API-DMAC7.html) | ||
| JP2010529203A5 (cg-RX-API-DMAC7.html) | ||
| CN1898202A (zh) | 抗高胆固醇血症化合物 | |
| WO2008035359A2 (en) | Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives | |
| WO2007099553A2 (en) | 1,3-dioxane carboxylic acids | |
| US9273041B2 (en) | Compounds for the treatment of dyslipidemia and related diseases | |
| JP2016521279A5 (cg-RX-API-DMAC7.html) | ||
| JP2007527433A5 (cg-RX-API-DMAC7.html) | ||
| US20150051144A1 (en) | Compounds for the treatment of dyslipidemia and other diseases | |
| CA2598725A1 (en) | Fused aromatic compounds having anti-diabetic activity |